GOLO Open-Label Pilot 1

Status Completed

Clinical Trial Summary

The objective of this open-label pilot study is to evaluate the effect of the commercially available GOLO for Life (GFL) weight management program on body weight in a type 2 diabetic patient population after approximately 3 months.

Clinical Trial Description

Golo For Life (GFL) is a weight management program that helps people who are overweight or obese limit and portion their consumption of conventional foods and make healthier choices in their diets. GFL includes a point-based system from the four macronutrient food groups that is based on the individual's activity level and body mass. Additionally, GFL includes common-sense instructions, motivation and tips supporting compliance and requires a minimum of 15 minutes of exercise per day. GFL also includes a dietary supplement containing zinc and chromium, essential nutrients that support regulation of blood sugar.

In case studies from clinician and wellness program use, GFL has shown the ability to reduce body weight in both healthy and diabetic people who are overweight or obese. Secondary endpoints including measures of blood sugar have been observed to decrease as a result of the GFL program.

While GFL has been developed and used in private clinical practice in both healthy overweight and type 2 diabetic people, more systematic research is needed to determine to what extent it is able to support healthy weight loss. This open-label pilot study is intended to observe the effects of the program in a representative group of subjects with stable type 2 diabetes at one outpatient medical practice.

The objective of this open-label pilot study is to evaluate the effect of the commercially available GOLO for Life (GFL) weight management program on body weight in a type 2 diabetic patient population after approximately 3 months. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT03478202
Study type	Interventional
Source	Golo
Contact
Status	Completed
Phase	N/A
Start date	August 1, 2017
Completion date	December 23, 2017

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT03596177` - A Study to Evaluate the Effect of MEDI0382 on Energy Balance in Overweight and Obese Participants With Type 2 Diabetes Mellitus	Phase 2
Completed	`NCT01728740` - Bioequivalence Study for Acarbose / Metformin FDC	Phase 1
Completed	`NCT02648854` - Investigate the Effect of Food on the Pharmacokinetic Characteristics of CKD-395 in Healthy Male Volunteers	Phase 1
Recruiting	`NCT02347020` - Impact of Sleep and Meal Timing on Food Intake Regulation	N/A
Completed	`NCT00577590` - Effects of Fatty Acid Delivery on Heart Metabolism and Function in Type 2 Diabetes (T2DM	N/A
Completed	`NCT00094796` - Rosiglitazone to Reverse Metabolic Defects in Diabetes	Phase 2
Completed	`NCT04830969` - Impact of Periodontal Therapy on Patients With Diabetes	Phase 2
Completed	`NCT03112382` - Effect of SLC30A8 rs13266634 Genetic Polymorphism on Zinc Supplementation and Glycemic Control in Egyptian Patients With Type 2 Diabetes Mellitus	Phase 4
Recruiting	`NCT01197092` - The Effects of a Regenerative Mitochondrial Medication on Physiological Parameters in Case of Diabetes Mellitus Type II	Phase 2
Completed	`NCT00649909` - Effect of Glucose Control on the Response to Aspirin in Type 2 Diabetic Patients	N/A
Terminated	`NCT00554697` - Diabetes Mellitus Type II and Tissue Oxygenation	N/A
Not yet recruiting	`NCT05957224` - Differences in Postprandial Glucose Changes	N/A
Active, not recruiting	`NCT02088658` - Technology Intensified Diabetes Education Study in African Americans	N/A
Completed	`NCT00081328` - Treatment Options for Type 2 Diabetes in Adolescents and Youth (TODAY)	Phase 3
Completed	`NCT00482079` - A Study of MK0431 in Patients With Type 2 Diabetes (0431-010)	Phase 2
Recruiting	`NCT04092738` - ´Sit Less, Move More` at Work: mHealth Intervention on Office Employees With Diabetes Type 2.	N/A
Completed	`NCT03012074` - Episodic to Real-Time Care in Diabetes Self-Management	N/A
Completed	`NCT02175537` - Microclinic Social Induction Pilot Intervention for Diabetes and Obesity Management in Qatar	N/A
Completed	`NCT01651065` - Micro-Clinic Obesity and Metabolic Risk Prevention Program	N/A
Completed	`NCT00528918` - Comparison of Apidra to Regular Insulin in Hospitalized Patients	N/A